TCMBANKIN004208 |
nortracheloside |
|
C26H32O12 |
536.5 g/mol |
COC1=C(C=CC(=C1)CC2COC(=O)C2(CC3=CC(=C(C=C3)OC4C(C(C(C(O4)CO)O)O)O)OC)O)O |
TCMBANKIN019079 |
daphnin |
|
C15H16O9 |
340.28 g/mol |
C1=CC(=C(C2=C1C=CC(=O)O2)O)OC3C(C(C(C(O3)CO)O)O)O |
TCMBANKIN021833 |
Daphnetin-8-glucoside |
NP-002391; 7-hydroxy-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-2-one; 7-hydroxy-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one; Daphnetin glucoside; DTXSID40174971; MolPort-001-740-986; NCGC00380261-01!7-hydroxy-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one; 7-hydroxy-8-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-2-chromenone; FT-0697994; 7-hydroxy-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-coumarin; 7-hydroxy-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-2-one; 2H-1-Benzopyran-2-one, 8-(beta-D-glucopyranosyloxy)-7-hydroxy-; 20853-56-9; AC1NSU5Y; MCULE-6518912539; ZINC31157928; daphnetin-8-glucoside; 7-HYDROXY-8-{[(2S,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL]OXY}CHROMEN-2-ONE |
C15H16O9 |
340.28 |
C1=CC(=C(C2=C1C=CC(=O)O2)OC3C(C(C(C(O3)CO)O)O)O)O |
TCMBANKIN021936 |
wilfordconine |
|
|
|
CC1C2=C(C=NC=C2)C(=O)OCC3(C4C(C(C5(C(C(C(C(C5(C4OC(=O)C)O3)(C)O)OC(=O)C1(C)O)O)OC(=O)C)COC(=O)C)OC(=O)C)OC(=O)C6=COC=C6)C |
TCMBANKIN032323 |
daphnetin-7-methyl ether |
|
C10H8O4 |
192.17 g/mol |
COC1=C(C2=C(C=C1)C=CC(=O)O2)O |
TCMBANKIN058178 |
Daphnetol |
5-18-03-00211 (Beilstein Handbook Reference); AIDS-026334; HSCI1_000053; NSC 633563; EU-0000106; ZINC00057753; AIDS026334; 2H-1-Benzopyran-2-one, 7,8-dihydroxy- (9CI); KBio1_001904; 7,8-Dihydroxy-2H-1-benzopyran-2-one; KBioGR_001808; 7,8-Dihydroxycoumarin; 7,8-dihydroxy-coumarin; 7,8-dihydroxychromen-2-one; NCGC00015349-01; D5564_SIGMA; Daphnetin; CHEBI:17313; Oprea1_044324; 486-35-1; NSC633563; Spectrum3_000784; KBio3_001708; COUMARIN, 7,8-DIHYDROXY-; 7,8-dihydroxy-2H-chromen-2-one; Lopac0_000330; ST5308908; 2H-1-Benzopyran-2-one, 7,8-dihydroxy-; Spectrum4_001254; BSPBio_002488; C03093; Lopac-D-5564; DivK1c_006960; EINECS 207-632-8; 630764_ALDRICH; BRN 0009372; EU-0100330; SpecPlus_000864; InChI=1/C9H6O4/c10-6-3-1-5-2-4-7(11)13-9(5)8(6)12/h1-4,10,12; 7,8-dihydroxy-2-chromenone; 4,8-Dihydroxycoumarin; AC-5538; ZINC21992842; 4,8-Dihydroxy-2H-chromen-2-one; BC216210; 7,8-dihydroxycoumarin; AKOS006290013; AK516453; daphnetin |
C9H6O4 |
178.14 g/mol |
C1=CC(=C(C2=C1C=CC(=O)O2)O)O |
TCMBANKIN058840 |
angelin |
umbelliprenin2021/11/13; 532-16-1; (E,E)-7-((3,7,11-Trimethyl-2,6,10-dodecatrienyl)oxy)-2H-1-benzopyran-2-one; ZINC02126785; 7-[(2E)-3,7,11-trimethyldodeca-2,6,10-trienoxy]coumarin; 7-(3,7,11-trimethyldodeca-2,6,10-trienoxy)coumarin; 7-[(2E)-3,7,11-trimethyldodeca-2,6,10-trienoxy]-2-chromenone; 7-(3,7,11-trimethyldodeca-2,6,10-trienoxy)-2-chromenone; 7-(3,7,11-trimethyldodeca-2,6,10-trienoxy)chromen-2-one; A1784/0075600; 7-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienoxy]coumarin; 30413-87-7; 7-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienoxy]-2-chromenone; 7-[(2E)-3,7,11-trimethyldodeca-2,6,10-trienoxy]chromen-2-one; 7-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienoxy]chromen-2-one |
C24H30O3 |
366.5 g/mol |
CC(=CCCC(=CCCC(=CCOC1=CC2=C(C=C1)C=CC(=O)O2)C)C)C |
TCMBANKIN061526 |
Thymelol;daphnoretin |
ZINC00689683; TNP00178; Oprea1_038414; NCGC00142383-01; 2034-69-7; NCGC00017271-01; AIDS-071129; 7-hydroxy-3-(2-ketochromen-7-yl)oxy-6-methoxy-coumarin; C09216; 7-hydroxy-6-methoxy-3-[(2-oxo-7-chromenyl)oxy]-2-chromenone; 7-hydroxy-6-methoxy-3-(2-oxochromen-7-yl)oxy-chromen-2-one; Daphnoretin; TimTec1_001767; NSC 291852; MLS001048954; MLS000728531; ST024716; BRN 1299325; 2H-1-Benzopyran-2-one, 7-hydroxy-6-methoxy-3-((2-oxo-2H-1-benzopyran-7-yl)oxy)-;7-hydroxyl-6-methoxy-3,7'-dicoumaryl ether; daphnoretin (9CI); 2H-1-Benzopyran-2-one, 7-hydroxy-6-methoxy-3-[(2-oxo-2H-1-benzopyran-7-yl)oxy]-; 2H-1-Benzopyran-2-one, 7-hydroxy-6-methoxy-3-((2-oxo-2H-1-benzopyran-7-yl)oxy)-; SMR000156224; AIDS071129; MLS000574856; NSC291852; 7-hydroxy-6-methoxy-3-(2-oxochromen-7-yl)oxychromen-2-one; COUMARIN, 7-HYDROXY-6-METHOXY-3,7'-OXYDI- |
C19H12O7 |
352.29 |
COC1=C(C=C2C(=C1)C=C(C(=O)O2)OC3=CC4=C(C=C3)C=CC(=O)O4)O |
TCMBANKIN009580 |
gniditrin |
|
C37H42O10 |
646.7 g/mol |
CCCC=CC=CC=CC(=O)OC1C(C23C4C=C(C(=O)C4(C(C5(C(C2C6C1(OC(O6)(O3)C7=CC=CC=C7)C(=C)C)O5)CO)O)O)C)C |
TCMBANKIN010247 |
daphneticin |
|
C20H18O8 |
386.4 g/mol |
COC1=CC(=CC(=C1O)OC)C2C(OC3=C(O2)C=CC4=C3OC(=O)C=C4)CO |
TCMBANKIN019083 |
daphneolone |
HMS2270K20; 3-hydroxy-1-(4-hydroxyphenyl)-5-phenylpentan-1-one; Daphneolone; daphneolon; MolPort-039-338-818; SMR001397060; CHEMBL1724888; MLS002472952; 54835-64-2; FT-0698570; AC1NSU5V |
C17H18O3 |
270.32 g/mol |
C1=CC=C(C=C1)CCC(CC(=O)C2=CC=C(C=C2)O)O |
TCMBANKIN046979 |
Odoracin |
NSC270919; Odoracin; NSC-270919; 66673-22-1; Yuanhuacium ester A; LS-145414; Stillingia factor S(sub 6); Yuanhuacin; Gnidilatidin; SCHEMBL15730513; Yuanhuatie; 61913-72-2; Yuanhuacine; Simplexin, 12-(benzoyloxy)-22,23,24,25-tetradehydro-, (12-beta,22E,24E)- |
|
648.7 g/mol |
|
TCMBANKIN049129 |
Daphnodorin B |
|
|
542.5 g/mol |
|
TCMBANKIN049365 |
Odoratrin |
|
|
648.7 g/mol |
|